Biogen Idec Biotech India Pvt. Ltd., of Haryana, India, gained Tecfidera (dimethyl fumarate) approval, the first oral therapy approved in the country to treat people with relapsing-remitting multiple sclerosi (MS). The company said it plans to launch the therapy in the Indian market in the second week of February.